Why Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Stock Slipped -3.30% in Last Month?
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
Is Catalyst Pharmaceuticals Inc (CPRX) Stock A Better Investment Than Its Rivals?
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
Why Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Stock went down -9.59% in Last Year?
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
Risks and Returns of Catalyst Pharmaceuticals Inc (CPRX) Stock
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
Catalyst Pharmaceuticals Inc (CPRX) Stock Experiences Incredible Growth
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
A New Look at Catalyst Pharmaceuticals Inc (CPRX) Stock’s Hidden Strategies
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
Catalyst Pharmaceuticals Inc (CPRX) Stock is the one stock you should own forever
Citigroup raised the price target for the Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) stock to “a Buy”. The rating was released on March 14, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $30. The stock was downgraded by ROTH Capital, who disclosed in a […]
